IGF1R and neoplasm: Similarly, overexpression of IGF1R markedly exacerbated tumor growth, treatment with surufatinib significantly reduced tumor burden in oeIGF1R-expressing mice, an effect that was further enhanced by the addition of the IGF1R inhibitor linsitinib (Fig.S4J, K).